Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wenjun Ouyang

Showing results (71-80 of 107) with videos related to

Pageof 11
Sort By:
Nature Medicine|February 12, 2008
Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogensYan Zheng, Patricia A Valdez, Dimitry M Danilenko, et al.
The Journal of Experimental Medicine|July 1, 2009
STAT3 links IL-22 signaling in intestinal epithelial cells to mucosal wound healingGeethanjali Pickert, Clemens Neufert, Moritz Leppkes, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 18, 2010
IL-17RC is required for immune signaling via an extended SEF/IL-17R signaling domain in the cytoplasmic tailAllen W Ho, Fang Shen, Heather R Conti, et al.
Nature|August 15, 2014
Interleukin-22 alleviates metabolic disorders and restores mucosal immunity in diabetesXiaoting Wang, Naruhisa Ota, Paolo Manzanillo, et al.
Pharmacology Research & Perspectives|November 23, 2018
Nonclinical safety assessment of a human interleukin-22FC IG fusion protein demonstrates in vitro to in vivo and cross-species translatabilityDonna W Lee, Shelly Zhong, Rama Pai, et al.
Infection and Immunity|November 1, 2011
Dectin-1-dependent interleukin-22 contributes to early innate lung defense against Aspergillus fumigatusMelissa A Gessner, Jessica L Werner, Lauren M Lilly, et al.
Bioorganic & Medicinal Chemistry Letters|November 19, 2013
Structure-based design of substituted hexafluoroisopropanol-arylsulfonamides as modulators of RORcBenjamin P Fauber, Gladys de Leon Boenig, Brenda Burton, et al.
The Journal of Experimental Medicine|April 26, 2021
STARTRAC analyses of scRNAseq data from tumor models reveal T cell dynamics and therapeutic targetsDev Bhatt, Boxi Kang, Deepali Sawant, et al.
Cell|June 17, 2017
Landscape of Infiltrating T Cells in Liver Cancer Revealed by Single-Cell SequencingChunhong Zheng, Liangtao Zheng, Jae-Kwang Yoo, et al.
Journal of Medicinal Chemistry|June 11, 2015
Discovery of 1-{4-[3-fluoro-4-((3s,6r)-3-methyl-1,1-dioxo-6-phenyl-[1,2]thiazinan-2-ylmethyl)-phenyl]-piperazin-1-yl}-ethanone (GNE-3500): a potent, selective, and orally bioavailable retinoic acid receptor-related orphan receptor C (RORc or RORγ) inverse agonistBenjamin P Fauber, Olivier René, Yuzhong Deng, et al.
Pageof 11

Showing results (71-80 of 107) with videos related to

Sort By:
Pageof 11
Nature Medicine|February 12, 2008
Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogensYan Zheng, Patricia A Valdez, Dimitry M Danilenko, et al.
The Journal of Experimental Medicine|July 1, 2009
STAT3 links IL-22 signaling in intestinal epithelial cells to mucosal wound healingGeethanjali Pickert, Clemens Neufert, Moritz Leppkes, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 18, 2010
IL-17RC is required for immune signaling via an extended SEF/IL-17R signaling domain in the cytoplasmic tailAllen W Ho, Fang Shen, Heather R Conti, et al.
Nature|August 15, 2014
Interleukin-22 alleviates metabolic disorders and restores mucosal immunity in diabetesXiaoting Wang, Naruhisa Ota, Paolo Manzanillo, et al.
Pharmacology Research & Perspectives|November 23, 2018
Nonclinical safety assessment of a human interleukin-22FC IG fusion protein demonstrates in vitro to in vivo and cross-species translatabilityDonna W Lee, Shelly Zhong, Rama Pai, et al.
Infection and Immunity|November 1, 2011
Dectin-1-dependent interleukin-22 contributes to early innate lung defense against Aspergillus fumigatusMelissa A Gessner, Jessica L Werner, Lauren M Lilly, et al.
Bioorganic & Medicinal Chemistry Letters|November 19, 2013
Structure-based design of substituted hexafluoroisopropanol-arylsulfonamides as modulators of RORcBenjamin P Fauber, Gladys de Leon Boenig, Brenda Burton, et al.
The Journal of Experimental Medicine|April 26, 2021
STARTRAC analyses of scRNAseq data from tumor models reveal T cell dynamics and therapeutic targetsDev Bhatt, Boxi Kang, Deepali Sawant, et al.
Cell|June 17, 2017
Landscape of Infiltrating T Cells in Liver Cancer Revealed by Single-Cell SequencingChunhong Zheng, Liangtao Zheng, Jae-Kwang Yoo, et al.
Journal of Medicinal Chemistry|June 11, 2015
Discovery of 1-{4-[3-fluoro-4-((3s,6r)-3-methyl-1,1-dioxo-6-phenyl-[1,2]thiazinan-2-ylmethyl)-phenyl]-piperazin-1-yl}-ethanone (GNE-3500): a potent, selective, and orally bioavailable retinoic acid receptor-related orphan receptor C (RORc or RORγ) inverse agonistBenjamin P Fauber, Olivier René, Yuzhong Deng, et al.
Pageof 11